Contalgin Forðatafla 10 mg Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

contalgin forðatafla 10 mg

mundipharma a/s - morphini sulfas - forðatafla - 10 mg

Dimax Rapid (Diclomex Rapid) Filmuhúðuð tafla 50 mg Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

dimax rapid (diclomex rapid) filmuhúðuð tafla 50 mg

alvogen ehf. - diclofenacum kalíum - filmuhúðuð tafla - 50 mg

Myfortic Magasýruþolin tafla 180 mg Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

myfortic magasýruþolin tafla 180 mg

novartis healthcare a/s - mycophenolatum natríum - magasýruþolin tafla - 180 mg

Myfortic Magasýruþolin tafla 360 mg Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

myfortic magasýruþolin tafla 360 mg

novartis healthcare a/s - mycophenolatum natríum - magasýruþolin tafla - 360 mg

Mykofenolatmofetil Actavis Filmuhúðuð tafla 500 mg Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

mykofenolatmofetil actavis filmuhúðuð tafla 500 mg

actavis group ptc ehf. - mycophenolatum mofetil - filmuhúðuð tafla - 500 mg

Celvapan Union européenne - islandais - EMA (European Medicines Agency)

celvapan

nanotherapeutics bohumil, s.r.o. - whole virion influenza vaccine, inactivated containing antigen of strain a/california/07/2009 (h1n1)v - disease outbreaks; influenza, human; immunization - bóluefni - fyrirbyggjandi meðferð inflúensu af völdum a (h1n1) v 2009 veirunnar. celvapan ætti að vera notuð í samræmi við opinbera leiðsögn.

Iclusig Union européenne - islandais - EMA (European Medicines Agency)

iclusig

incyte biosciences distribution b.v. - ponatinib - leukemia, myeloid; leukemia, lymphoid - antineoplastic agents, protein kinase inhibitors - iclusig is indicated in adult patients withchronic phase, accelerated phase, or blast phase chronic myeloid leukaemia (cml) who are resistant to dasatinib or nilotinib; who are intolerant to dasatinib or nilotinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutationphiladelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) who are resistant to dasatinib; who are intolerant to dasatinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutation. sjá kafla 4. 2 assessment of cardiovascular status prior to start of therapy and 4. 4 situations where an alternative treatment may be considered.

Incruse Ellipta (previously Incruse) Union européenne - islandais - EMA (European Medicines Agency)

incruse ellipta (previously incruse)

glaxosmithkline (ireland) limited - skert umbrot brómíð - lungnasjúkdómur, langvarandi hindrandi - lyf til veikindi öndunarvegi sjúkdómum, - tilkynnt sem viðhaldsberkjuvíkkandi meðferð til að létta einkenni hjá fullorðnum sjúklingum með langvinna lungnateppu (copd).

Targretin Union européenne - islandais - EMA (European Medicines Agency)

targretin

eisai gmbh - bexarótín - eitilæxli, t-frumur, húð - Æxlishemjandi lyf - targretin hylki eru ætlaðar til meðhöndlunar á einkennum í húð hjá sjúklingum með sjúkdóm í t-frumu eitilfrumugerð í langt gengnu stigi, sem eru ónæmir fyrir að minnsta kosti einum almennri meðferð.

Galliprant Union européenne - islandais - EMA (European Medicines Agency)

galliprant

elanco gmbh - grapiprant - Önnur bólgueyðandi og verkjalyf lyf, ekki sterum - hundar - til meðferðar á verkjum sem tengjast vægum til í meðallagi slitgigt hjá hundum.